If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp Regulatory News (PEYS)

Share Price Information for Partners Grp (PEYS)

Share Price is delayed by 15 minutes
Get Live Data
638.00    3.00 (0.49%)
Bid:
602.00
Ask:
638.00
Spread: 36.00 (5.98%)
Market Cap: £428.20m
PEYS Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp Share Chart

PGPE Ltd publishes July NAV

4 Sep 2024 07:00

RNS Number : 8560C
Partners Group Private Equity Ltd
04 September 2024
 

(LSE: PEYS/PEY)

 

Partners Group Private Equity Limited

 

PGPE Ltd publishes July NAV

 

 

· NAV decreased by 0.7% to EUR 14.28 per share; total net assets at EUR 987.40 million

· Revaluations (-0.4%, of which -0.2% was due to the movement in the listed share price of Galderma), and currency movements (-0.4%) detracted from NAV

· PGPE Ltd invested EUR 2.2 million and received distributions of EUR 1.7 million

 

In July, the net asset value of PGPE Ltd decreased by 0.7%. The performance was partly driven by Galderma, a Switzerland-headquartered pharmaceutical company specializing in dermatological treatments and skin care products. The company is listed on the SIX Swiss Exchange and its share price saw a decline at the end of the month as a result of market compression. Nevertheless, the share price has since increased with the company announcing in August that it has signed a memorandum of understanding with L'Oréal to work towards a new research and development (R&D) collaboration. This would take the form of a scientific partnership focused on complementary research projects which could develop advanced, future-proof technologies with direct applications in the field of dermatology.

 

After the month's end, the Company held its semi-annual webcast to update investors on the recent developments of the portfolio. The recording is available under the following link.

 

Further information is available in the monthly report, which can be accessed via: https://www.partnersgroupprivateequitylimited.com/en/investor-relations/financial-reports/

 

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd (formerly Princess Private Equity Holding Limited) is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, a global private markets investment management firm with USD 149 billion in investment programs under management in private markets, of which USD 76 billion is in private equity. PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

Investor relations contact:

Andreea Mateescu

Phone: +41 41 784 66 73

E-mail: andreea.mateescu@partnersgroup.com

 

Media relations contact:

Jenny Blinch

Phone: +41 41 784 65 26

E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241 LEI: 54930038LU8RDPFFVJ57

Notes:

1. Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "Company". References to Partners Group AG have been abbreviated to "Partners Group" or "Investment Manager".

2. This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3. This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd' website nor the contents of any website accessible from hyperlinks on PGPE Ltd' website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGLKDRGDZG
Date   Source Headline
2nd Jan 20197:00 amRNSCompliance with Model Code
2nd Jan 20197:00 amRNSTotal Voting Rights
28th Dec 20184:35 pmRNSPrice Monitoring Extension
24th Dec 201812:35 pmRNSPrice Monitoring Extension
21st Dec 20184:47 pmRNSNotification of interests of Directors
21st Dec 20184:45 pmRNSPrincess publishes November NAV
4th Dec 20187:01 amRNSSecond Price Monitoring Extn
4th Dec 20187:01 amRNSPrice Monitoring Extension
3rd Dec 20184:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20184:35 pmRNSPrice Monitoring Extension
3rd Dec 20187:00 amRNSTotal Voting Rights
28th Nov 20187:00 amRNSPrincess publishes October NAV
22nd Nov 20187:00 amRNSPrincess Private Equity publishes Q3 report 2018
21st Nov 20184:40 pmRNSSecond Price Monitoring Extn
21st Nov 20184:35 pmRNSPrice Monitoring Extension
1st Nov 20187:00 amRNSTotal Voting Rights
30th Oct 20184:35 pmRNSPrice Monitoring Extension
25th Oct 20187:00 amRNSNAV increases by 2.1% in September
16th Oct 20187:00 amRNSDividend Declaration
1st Oct 20187:00 amRNSCompliance with Model Code
1st Oct 20187:00 amRNSTotal Voting Rights
26th Sep 20187:00 amRNSNAV increases by 0.2% in August
25th Sep 20184:26 pmRNSHolding(s) in Company
3rd Sep 20187:00 amRNSDirectorate Change
3rd Sep 20187:00 amRNSTotal Voting Rights
23rd Aug 20187:00 amRNSNAV increases by 1.1%
22nd Aug 20184:07 pmRNSNotification of interests of Directors
17th Aug 20183:00 pmRNSPrincess publishes Half-Year Report 2017
15th Aug 20183:49 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSQ2 2018 results
1st Aug 20187:00 amRNSTotal Voting Rights
30th Jul 20187:00 amRNSNAV increases by 2.7%
2nd Jul 20187:00 amRNSCompliance with Model Code
2nd Jul 20187:00 amRNSTotal Voting Rights
26th Jun 20187:00 amRNSNAV increases by 0.2%
15th Jun 20184:40 pmRNSSecond Price Monitoring Extn
15th Jun 20184:35 pmRNSPrice Monitoring Extension
1st Jun 20187:00 amRNSTotal Voting Rights
29th May 20187:00 amRNSNAV increases by 0.8%
17th May 20187:00 amRNSDividend announcement and Q1 report
16th May 20184:39 pmRNSResult of AGM
16th May 20184:28 pmRNSDirectorate Change
16th May 20184:15 pmRNSDividend Declaration
16th May 20182:55 pmRNSResult of AGM
14th May 20187:00 amRNSQ1 2018 results
1st May 20187:00 amRNSTotal Voting Rights
30th Apr 20187:00 amRNSNAV increases by 0.7%
18th Apr 20181:27 pmRNSNotification of interests of Directors
12th Apr 20187:48 amRNSNotice of AGM
3rd Apr 20187:00 amRNSCompliance with Model Code

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.